Sunitinib Alone or after Nephrectomy in Metastatic Renal‐Cell Carcinoma

Méjean, A.; Ravaud, A.; Thézénas, S.; Colas, Sandra; Beauval, J.; Bensalah, K.; Geoffrois, L.; Thiery-Vuillemin, A.; Cormier, L.; Lang, H.; Guy, L.; Gravis, G.; Rolland, F.; Linassier, C.; Lechevallier, É.; Beisland, C.; Aitchison, M.; Oudard, S.; Patard, J.; Théodore, C.; Chevreau, C.; Laguerre, B.; Hubert, J.; Gross-Goupil, M.; Bernhard, J.; Albiges, L.; Timsit, M.; Lebret, T.; Escudier, B.

doi:10.1056/NEJMoa1803675

Public

Sunitinib Alone or after Nephrectomy in Metastatic Renal‐Cell Carcinoma

Shared by NobleBlocks on Jun 3, 2018 • 12:00 AM UTC

Authors:

A. Méjean

A. Ravaud

S. Thézénas

Abstract

BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic renal‐cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. However, the efficacy of targeted therapies has challenged this standard. We assessed the role of nephrectomy in patien...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!